These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12959282)

  • 1. Cigarette smoking enhances the elimination of quinine.
    Wanwimolruk S; Wong SM; Coville PF; Viriyayudhakorn S; Thitiarchakul S
    Br J Clin Pharmacol; 1993 Dec; 36(6):610-4. PubMed ID: 12959282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.
    Wanwimolruk S; Kang W; Coville PF; Viriyayudhakorn S; Thitiarchakul S
    Br J Clin Pharmacol; 1995 Jul; 40(1):87-91. PubMed ID: 8527275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cigarette smoking on quinine pharmacokinetics in malaria.
    Pukrittayakamee S; Pitisuttithum P; Zhang H; Jantra A; Wanwimolruk S; White NJ
    Eur J Clin Pharmacol; 2002 Aug; 58(5):315-9. PubMed ID: 12185554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dose size on the pharmacokinetics of orally administered quinine.
    Sowunmi A; Salako LA
    Eur J Clin Pharmacol; 1996; 49(5):383-6. PubMed ID: 8866633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?
    Wanwimolruk S; Paine MF; Pusek SN; Watkins PB
    Br J Clin Pharmacol; 2002 Dec; 54(6):643-51. PubMed ID: 12492613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of quinine in plasma after a single oral and intramuscular dose in healthy adult Africans.
    Sowunmi A
    East Afr Med J; 1996 Feb; 73(2):111-4. PubMed ID: 8756050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of quinine in patients with chronic renal failure.
    Rimchala P; Karbwang J; Sukontason K; Banmairuroi V; Molunto P; Na-Bangchang K
    Eur J Clin Pharmacol; 1996; 49(6):497-501. PubMed ID: 8706776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral quinine pharmacokinetics and dietary salt intake.
    Newton P; Simpson A; Wanwimolruk S; Maliakal P; Villegas L; Kuypers D; White NJ
    Eur J Clin Pharmacol; 2001 May; 57(2):111-3. PubMed ID: 11417441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma and saliva quinine levels in humans.
    Babalola CP; Bolaji OO; Ogunbona FA; Dixon PA
    Ther Drug Monit; 1996 Feb; 18(1):30-3. PubMed ID: 8848817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria.
    Claessen FA; van Boxtel CJ; Perenboom RM; Tange RA; Wetsteijn JC; Kager PA
    Trop Med Int Health; 1998 Jun; 3(6):482-9. PubMed ID: 9657511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of quinine in obesity.
    Viriyayudhakorn S; Thitiarchakul S; Nachaisit S; Ho PC; Wanwimolruk S
    Trans R Soc Trop Med Hyg; 2000; 94(4):425-8. PubMed ID: 11127249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats.
    Zhang H; Wong CW; Coville PF; Wanwimolruk S
    Drug Metabol Drug Interact; 2000; 17(1-4):351-63. PubMed ID: 11201303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers.
    Soyinka JO; Onyeji CO; Omoruyi SI; Owolabi AR; Sarma PV; Cook JM
    J Pharm Pharmacol; 2009 Apr; 61(4):439-43. PubMed ID: 19298689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of quinine in young and elderly subjects.
    Wanwimolruk S; Chalcroft S; Coville PF; Campbell AJ
    Trans R Soc Trop Med Hyg; 1991; 85(6):714-7. PubMed ID: 1801332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrarectal administration of quinine: an early treatment for severe malaria in children?].
    Barennes H; Kailou D; Pussard E; Munjakazi JM; Fernan M; Sherouat H; Sanda A; Clavier F; Verdier F
    Sante; 2001; 11(3):145-53. PubMed ID: 11641075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinine unbound concentration is the best marker for therapeutic drug monitoring.
    de Pablos-Martinez C; Porte L; Fraissinet F; Berry A; Séraissol P; Lavit M; Chatelut E; Concordet D; Gandia P
    Therapie; 2016 Oct; 71(5):487-489. PubMed ID: 27203159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria.
    Barennes H; Sterlingot H; Nagot N; Meda H; Kaboré M; Sanou M; Nacro B; Bourée P; Pussard E
    Eur J Clin Pharmacol; 2003 Feb; 58(10):649-52. PubMed ID: 12610739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics of quinine.
    Wanwimolruk S; Chalcroft S
    Br J Clin Pharmacol; 1991 Nov; 32(5):617-20. PubMed ID: 1954076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of quinine in chronic liver disease.
    Auprayoon P; Sukontason K; Na-Bangchang K; Banmairuroi V; Molunto P; Karbwang J
    Br J Clin Pharmacol; 1995 Nov; 40(5):494-7. PubMed ID: 8703656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.